Phase 2/3 results show that the bivalent second booster that targets both the original virus and the Omicron variant was superior to the standard booster a month after vaccination across age groups.
A new report emphasizes the importance of celiac disease screening for all children whose first-degree relatives are affected, because symptom status may not be predictive of disease severity.